SCHEMBL9196674

SCHEMBL9196674

Cc1ccc2oc(C(CN)CC(=O)O)cc2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47
CA5A P35218 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
CA5B Q9Y2D0 1/20 0.47
TAS1R3 Q7RTX0 3/20 0.45
TAS1R1 Q7RTX1 3/20 0.45
ADAM17 P78536 3/20 0.44
MMP2 P08253 2/20 0.44
GABBR2 O75899 4/20 0.43
GABBR1 Q9UBS5 4/20 0.43
MMP9 P14780 1/20 0.42
LMNA P02545 2/20 0.40
CYP2C9 P11712 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9315754 0.84 PIM1 (0.55) CA12CA1CA2CA9ADAM17
SCHEMBL9203506 0.84 LMNA (0.43) CA12CA2CA4CA6CA7
SCHEMBL9198993 0.84 GABBR2 (0.44) GABBR2GABBR1LMNACYP2C9ADORA3
SCHEMBL9202393 0.83 GABBR2 (0.54) MAOBADAM17MMP2GABBR2GABBR1
SCHEMBL9196666 0.83 GABBR2 (0.43) CA12CA1CA2CA9GABBR2
SCHEMBL9195312 0.81 GAA (0.43) GABBR2GABBR1LMNACYP2C9ADORA3
SCHEMBL9200327 0.81 ALDH1A1 (0.45) MAOBCA12CA1CA4CA6
SCHEMBL9594099 0.80 PIM1 (0.57) MAOBMMP2GABBR2GABBR1MMP9
SCHEMBL658890 0.78 MAOB (0.47) MAOBCA12CA1CA2CA4
SCHEMBL9316733 0.75 TAS1R3 (0.48) MAOBCA12CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0463969-B1 New compounds of 4-aminobutyric acid, process for their preparation and pharmaceutical preparations containing them ADIR (FR) 1995-02-08 EP claimed
US-5278166-A 4-amino-3-heteroaryl butyric acid compounds, compositions, and their use for treating disorders involving a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1994-01-11 US disclosed
US-5214063-A 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1993-05-25 US disclosed
US-5162364-A Treatment of spastic and senescence disorders ADIR ET COMPAGNIE (FR) 1992-11-10 US disclosed